Literature DB >> 4563493

Parkinson's disease. Modification by 5-hydroxytryptophan.

T N Chase, L K Ng, A M Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4563493     DOI： 10.1212/wnl.22.5.479

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  9 in total

Review 1.  Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data.

Authors:  B Scholtissen; F R J Verhey; H W M Steinbusch; A F G Leentjens
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

2.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

3.  Dopamine correlates of neurological and psychological status in untreated Parkinsonism.

Authors:  M M Hoehn; T J Crowley; C O Rutledge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-10       Impact factor: 10.154

4.  Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.

Authors:  S Castells; C Chakrabarti; B G Winsberg; M Hurwic; J M Perel; W L Nyhan
Journal:  J Autism Dev Disord       Date:  1979-03

5.  Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant.

Authors:  H Y Meltzer; M Young; J Metz; V S Fang; P M Schyve; R C Arora
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

6.  Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations.

Authors:  D A Loeffler; P A LeWitt; P L Juneau; D M Camp; A J DeMaggio; M K Havaich; P E Milbury; W R Matson
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

7.  CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.

Authors:  D L Davidson; C M Yates; C Mawdsley; I A Pullar; H Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-12       Impact factor: 10.154

Review 8.  Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.

Authors:  P Jenner; M Sheehy; C D Marsden
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

9.  Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.

Authors:  K Ikeguchi; A Kuroda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.